Austin, TX – Paradromics Inc. has announced the appointment of William Marks as Chief Clinical Officer. About Paradromics Inc.: Paradromics Inc. is a neurotechnology company focused on building brain-computer interface, or BCI, systems that capture brain activity at the level of individual neurons and translate it into useful communication and control. The companys site presents its vision of BCIs becoming so seamless that they disappear into our conscious experience, and describes brain interfaces as a plus AI technology. Its primary product is the Connexus BCI, which is designed to help people with severe motor impairments communicate through text, synthesized speech, and computer control. Paradromics positions itself as working on high-data-rate BCI technology for serious unmet medical needs, especially for people affected by conditions such as ALS, stroke, and spinal cord injury. The company also highlights a major milestone on its site: the successful first human implantation of the Connexus BCI as part of the FDA-approved Connect-One study in June 2026.

For more information visit: https://paradromics.com/

Paradromics Inc.
4030 West Braker Lane Building 2, Suite 100
Austin, TX 78759
Phone: 512-559-4120
LinkedIn: https://www.linkedin.com/company/paradromics-inc/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved